1. Home
  2. DRS vs RGEN Comparison

DRS vs RGEN Comparison

Compare DRS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leonardo DRS Inc.

DRS

Leonardo DRS Inc.

HOLD

Current Price

$34.43

Market Cap

9.7B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$156.66

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRS
RGEN
Founded
1969
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DRS
RGEN
Price
$34.43
$156.66
Analyst Decision
Strong Buy
Buy
Analyst Count
6
10
Target Price
$46.83
$170.90
AVG Volume (30 Days)
888.1K
724.0K
Earning Date
10-29-2025
10-28-2025
Dividend Yield
1.04%
N/A
EPS Growth
33.93
N/A
EPS
0.99
0.03
Revenue
$3,569,000,000.00
$707,890,000.00
Revenue This Year
$11.94
$17.84
Revenue Next Year
$6.66
$12.57
P/E Ratio
$34.83
$5,097.58
Revenue Growth
12.27
11.74
52 Week Low
$28.17
$102.97
52 Week High
$49.31
$182.52

Technical Indicators

Market Signals
Indicator
DRS
RGEN
Relative Strength Index (RSI) 45.19 47.50
Support Level $33.68 $160.11
Resistance Level $34.90 $165.02
Average True Range (ATR) 0.75 4.97
MACD 0.35 -1.27
Stochastic Oscillator 73.95 7.12

Price Performance

Historical Comparison
DRS
RGEN

About DRS Leonardo DRS Inc.

Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: